• Aberrant migration features in primary skin fibroblasts of Huntington's disease patients hold potential for unraveling disease progression using an image based machine learning tool
• Advances in Gene and Cellular Therapeutic Approaches for Huntington's Disease
• Alcohol- and Low-Iron Induced Changes in Antioxidant and Energy Metabolism Associated with Protein Lys Acetylation
• An automatic measure for speech intelligibility in dysarthrias-validation across multiple languages and neurological disorders
• An Interesting Finding of Xanthogranulomatous Pyelonephritis Revealed Concomitant Incidental Squamous Cell Carcinoma (SCC) of the Renal Pelvis
• Ant colony optimization for the identification of dysregulated gene subnetworks from expression data
• Application of Casein Micelles for Targeting Huntington's Disease in Experimental Zebrafish Model
• Autoimmune Movement Disorders
• Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington's disease
• Binding structures of SERF1a with NT17-polyQ peptides of huntingtin exon 1 revealed by SEC-SWAXS, NMR and molecular simulation
• Causal associations of physical activity and leisure sedentary behaviors with age at onset of Huntington's disease: A mendelian randomization study
• Changes in cerebral vascular reactivity following mild repetitive head injury in awake rats: modeling the human experience
• Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial
• Cholesterol imbalance and neurotransmission defects in neurodegeneration
• Coffee, antioxidants, and brain inflammation
• Colchicine for cardiovascular and limb risk reduction in Medicare beneficiaries with peripheral artery disease: emulation of target trials
• Combining features on vertical ground reaction force signal analysis for multiclass diagnosing neurodegenerative diseases
• Comparing balance using the BESTest in Alzheimer, Huntington and Parkinson disease
• Comprehensive identification of ubiquitin-like 3 (UBL3)-interacting proteins in the mouse brain
• Computerized Cognitive Training Increases Gray Matter Volumes in Huntington's Disease: A Pilot Study
• Coping with Huntington's Disease in Patients and At-Risk Individuals
• Corrigendum to "Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model" [Brain Behav. Immun. 120 (2024) 413-429]
• COVID-19 vaccination hesitance and adverse effects among US adults: a longitudinal cohort study
• COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals
• Deciphering the spectrum of astrocyte diversity: Insights into molecular, morphological, and functional dimensions in health and neurodegenerative diseases
• Detection of Mycobacterium tuberculosis transrenal DNA in urine samples among adults in Peru
• Disrupted brain functional connectivity as early signature in cognitively healthy individuals with pathological CSF amyloid/tau
• Dysregulation of choline metabolism and therapeutic potential of citicoline in Huntington's disease
• Economic Burden of Huntington's Disease: Analysis from a Brazilian Tertiary Care Perspective
• Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial
• Emerging pharmacological approaches for Huntington's disease
• Epigenetics in rare neurological diseases
• Epsins oversee smooth muscle cell reprogramming by influencing master regulators KLF4 and OCT4
• Evidence-based review on symptomatic management of Huntington's disease
• Excitotoxicity, Oxytosis/Ferroptosis, and Neurodegeneration: Emerging Insights into Mitochondrial Mechanisms
• Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington disease models
• Exploring the therapeutic potential: Apelin-13's neuroprotective effects foster sustained functional motor recovery in a rat model of Huntington's disease
• Factors Influencing Discharges to Hospice for Patients With Late-Stage Huntington's Disease
• Fluorescence-Based Monitoring of Early-Stage Aggregation of Amyloid-β, Amylin Peptide, Tau, and α-Synuclein Proteins
• Friend or foe: Lactate in neurodegenerative diseases
• Global burden of gynaecological cancers in 2022 and projections to 2050
• Huntingtin contains an ubiquitin-binding domain and regulates lysosomal targeting of mitochondrial and RNA-binding proteins
• Huntingtin lowering impairs the maturation and synchronized synaptic activity of human cortical neuronal networks derived from induced pluripotent stem cells
• Huntington's disease cellular phenotypes are rescued non-cell autonomously by healthy cells in mosaic telencephalic organoids
• Hydrogen sulfide reduces oxidative stress in Huntington's disease via Nrf2
• Hyperkalemia and risk of chronic kidney disease progression: A propensity score matched analysis
• Identification of molecular targets and small drug candidates for Huntington's disease via bioinformatics and a network-based screening approach
• Impact of federal antipsychotic use policy in nursing homes on new diagnoses for approved indications in dementia residents
• Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders
• Interaction between resveratrol and SIRT1: role in neurodegenerative diseases
• Linking coronary artery disease to neurodegenerative diseases through systems genetics
• Long-Term Dementia Risk in Parkinson Disease
• Long-Term Health Outcomes of Huntington Disease and the Impact of Future Disease-Modifying Treatments: A Decision-Modeling Analysis
• LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models
• Mechanism and treatment of intracerebral hemorrhage focus on mitochondrial permeability transition pore
• Metal Ion Binding to Human Glutaminyl Cyclase: A Structural Perspective
• Molecular targets of caffeine in the central nervous system
• Multi-omic analysis of Huntington's disease reveals a compensatory astrocyte state
• Mutant Huntingtin Drives Development of an Advantageous Brain Early in Life: Evidence in Support of Antagonistic Pleiotropy
• Mutant huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure
• Neuroprotection by ADAM10 inhibition requires TrkB signaling in the Huntington's disease hippocampus
• Nuclear poly-glutamine aggregates rupture the nuclear envelope and hinder its repair
• Osmotic gradient ektacytometry - a novel diagnostic approach for neuroacanthocytosis syndromes
• Palmitoylation of synaptic proteins: roles in functional regulation and pathogenesis of neurodegenerative diseases
• Peripheral sequestration of huntingtin delays neuronal death and depends on N-terminal ubiquitination
• Person-centred integrated care for people living with Parkinson's, Huntington's and Multiple Sclerosis: A systematic review
• Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first-in-human study
• Phenomenological patterns and aetiological spectrum in patients visiting a tertiary care Movement disorders service in India: An observational study
• Presymptomatic Targeted Circuit Manipulation for Ameliorating Huntington's Disease Pathogenesis
• Prevalence of Juvenile-Onset and Pediatric Huntington's Disease and Their Availability and Ability to Participate in Trials: A Dutch Population and Enroll-HD Observational Study
• Probiotic Functions in Fermented Foods: Anti-Viral, Immunomodulatory, and Anti-Cancer Benefits
• Prognostic enrichment for early-stage Huntington's disease: An explainable machine learning approach for clinical trial
• Progress of ATM inhibitors: Opportunities and challenges
• Protein modification in neurodegenerative diseases
• Protocol for a randomised controlled unblinded feasibility trial of HD-DRUM: a rhythmic movement training application for cognitive and motor symptoms in people with Huntington's disease
• Psychiatric Manifestations of Neurological Diseases: A Narrative Review
• Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological Disorders
• Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
• Scheduled feeding improves sleep in a mouse model of Huntington's disease
• Silymarin ameliorates motor function and averts neuroinflammation-induced cell death in the rat model of Huntington's disease
• Simultaneous time-frequency analysis of gait signals of both legs in classifying neurodegenerative diseases
• Stress-Related Roles of Exosomes and Exosomal miRNAs in Common Neuropsychiatric Disorders
• Structural brain differences in the Alzheimer's disease continuum: Insights into the heterogeneity from a large multi-site neuroimaging consortium
• Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging
• Synthesis of aspartic acid and tyrosine by the fire blight pathogen Erwinia amylovora is not required for proliferation on apple flower stigmas or virulence in fruitlets
• TDP43 and Huntingtin Exon-1 Undergo A Conformationally Specific Interaction That Strongly Alters the Fibril Formation of Both Proteins
• The Frequency and Clinical Impact of Synonymous HTT Loss-of-Interruption and Duplication-of-interruption Variants in a Diverse HD Cohort
• The impact of COVID-19 pandemic on patients with Huntington's disease and care-givers: A French survey
• The meaning of apathy in Huntington's disease: A qualitative study of caregiver perspectives
• The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease
• The role of interferon beta in neurological diseases and its potential therapeutic relevance
• Time to Functional Loss as an Endpoint in Huntington's Disease Trials: Enrichment and Sample Size
• Transcarotid TAVR for Severe Bicuspid Aortic Stenosis With Virtually Atretic Coarctation of the Thoracic Aorta
• Transcriptomics analysis reveals potential regulatory role of nSMase2 (Smpd3) in nervous system development and function of middle-aged mouse brains
• Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol
• Understanding the implications of a complete case analysis for regression models with a right-censored covariate
• Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases
• Unraveling the Molecular Complexity of N-Terminus Huntingtin Oligomers: Insights into Polymorphic Structures
• Vascular Leukoencephalopathy Associated Chorea Due to A Heterozygous Htra 1 Variant: Novel Presentation of Cadasil Type II
• Virtual reality tolerability, sense of presence and usability in Huntington disease: a pilot study